Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists. 2008

Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 8 Clarke Drive, Cranbury, NJ 08512, USA. mxia@prdus.jnj.com

The synthesis and structure-activity relationship of a series of 7-azaindole piperidine derivatives are described. SAR studies led to the discovery of the potent CCR2 antagonists displaying IC(50) values in the nanomolar range. The representative compound 15 showed reasonable P450 and pharmacokinetics profile.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D010880 Piperidines A family of hexahydropyridines.
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000438 Alcohols Alkyl compounds containing a hydroxyl group. They are classified according to relation of the carbon atom: primary alcohols, R-CH2OH; secondary alcohols, R2-CHOH; tertiary alcohols, R3-COH. (From Grant & Hackh's Chemical Dictionary, 5th ed)
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
January 2020, Bioorganic & medicinal chemistry letters,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
March 2009, Bioorganic & medicinal chemistry letters,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
April 2023, Bioorganic chemistry,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
November 2008, Bioorganic & medicinal chemistry letters,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
September 2010, Bioorganic & medicinal chemistry letters,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
January 2015, European journal of medicinal chemistry,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
January 2008, Pakistan journal of pharmaceutical sciences,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
May 2011, Yao xue xue bao = Acta pharmaceutica Sinica,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
May 1988, Journal of medicinal chemistry,
Mingde Xia, and Cuifen Hou, and Duane DeMong, and Scott Pollack, and Meng Pan, and Monica Singer, and Michele Matheis, and William Murray, and Druie Cavender, and Michael Wachter
November 2023, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!